Plant Health Care (LON: PHC), a leading provider of novel patent-protected biological products to global agriculture markets, announced the appointment of Arden Partners Plc as the Company’s sole broker and
Plant Health Care (LON:PHC), a leading provider of novel patent-protected biological products to global agriculture markets, recently announced a move into the US with corn. Joining DirectorsTalk to discuss the
Plant Health Care’s Dr Chris Richards discusses their interim results for the six months ended 30th June 2018 in this exclusive interview with DirectorsTalk
Plant Health Care plc (LON:PHC) CEO Dr Chris Richards talks to DirectorsTalk about it’s interim results for the 6 months ended 30th June 2018. Chris talks us through the highlights,
Plant Health Care, Dr. Christopher Richards, Executive Chairman and Interim CEO, commented: “The progress of our Commercial business in 2018 is not reflected in our first half sales, because of
Chris Richards, Executive Chairman and Interim CEO of Plant Health Care noted: “This is an excellent opportunity for Plant Health Care to gain access to the 90 million acre US
Jeff Tweedy, Commercial Head, Americas for Plant Health Care, said: “We are very encouraged by the support we are receiving from Coplacana in promoting H2Copla in the field and have
Plant Health Care’s Dr Chris Richards discusses the performance of their commercial products, the cash-positive goal, Innatus 3G licencing and the development of the PREtec peptides in this exclusive interview with DirectorsTalk
Plant Health Care Plc (LON:PHC) CEO, Dr Chris Richards talks to DirectorsTalk about the performance of its commercial products, becoming cash positive, Innatus 3G licensing and developments in trials on
Chris Richards, Interim CEO and Executive Chairman, commented: “The acceleration of our Commercial business is exciting and reinforces our confidence in bringing the Company to cash positive within our existing
© 2024 – DirectorsTalk. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.
